ICICI Life Insurance shares: Despite 34% slump in 2026, Religare sees 42% upside post Q2 results
60-Word AI Digest
Religare Broking reiterated its ‘Buy’ rating on ICICI Life Insurance, with a target price of ₹650, implying a 42.6% upside. The brokerage cited leadership continuity, distribution strategy and operating efficiency as key growth drivers, while flagging near-term softness in some product segments.
Key Takeaways
- Religare Broking reiterated its ‘Buy’ rating on ICICI Life Insurance, with a target price of ₹650, implying a 42.6% upside.
- The brokerage cited leadership continuity, distribution strategy and operating efficiency as key growth drivers, while flagging near-term softness in some product segments.
- Full details and original dispatch available below.
Religare Broking reiterated its ‘Buy’ rating on ICICI Life Insurance, with a target price of ₹650, implying a 42.6% upside. The brokerage cited leadership continuity, distribution strategy and operating efficiency as key growth drivers, while flagging near-term softness in some product segments.
Original Publisher Attribution
This summary was curated from Here's why.